The ABOM Pathway For psychiatrists serious about this, the American Board of Obesity Medicine offers a certification that legitimizes your scope
We are dedicated to helping you achieve lasting metabolic health through a combination of modern science and personalized care
Clear protocols Read More GLP-1 Drug Interactions: Why New Prescribing Patterns Are Raising Concerns Mar 26, 2026 Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity 6,213 views Concerns about GLP-1 drug interactions are rising as these therapies gain widespread use in diabetes and obesity management
The first few days can feel challenging
Final Checks and Follow-up: When the study is finished, participants have their last health checks
Watch this quick tutorial video which takes you around the website